It is hypothesized that IL-15 promotes tumor progression via induction of survival and anti-apoptotic signals in malignant T-cells [75], while IL-32 has been shown to accelerate the proliferation of CTCL cell lines through MAPK and NF-KB dependent mechanisms [76]. This evidence concerns the gene IL15 and neoplasm.